Entries by bps

[Medical Today] China, Emerging Market in Global Drug Industry, Pays Attention to New Korean Drugs

Recently, China has innovated various drug and medical regulations, and multinational pharmaceutical companies are advancing into China one after another. While it is emerging as a global market, new Korean drugs are attracting attention in the Chinese market. According to the Korea Drug Development Fund, Biocentury and Bayhelix Group held the ‘Biocentury China Healthcare […]

[Yakup Shinmun] Forum for Discussion Held in Shanghai for Chinese Pharmaceutical Industry

At the 5th ‘China Summit’, new Korean drug development performance was introduced. Biocentury and Bayhelix Group held the ‘BioCentury-China Healthcare Summit (China Summit).’ Four hundred and fifty pharmaceutical and bio-pharma leaders from 16 countries gathered together at the China Summit, which was held in Shanghai, China from November 13 to November 14, and discussed […]

IR/PR

The oral medication for infantile spasms (IS) is in phase 2 clinical trialsin Korea and the US, and the IV medication for status epilepticus (SE) is in phase 1 clinical trials in the US. The company has established new pipelines, including Alzheimer’s Disease, and is set to embark on clinical trials (phase 2)… by expanding […]

IR/PR

The oral medication for infantile spasms (IS) is in phase 2 clinical trialsin Korea and the US, and the IV medication for status epilepticus (SE) is in phase 1 clinical trials in the US. The company has established new pipelines, including Alzheimer’s Disease, and is set to embark on clinical trials (phase 2)… by expanding […]

Bio-Pharm Solutions

145, Gwanggyo-ro, Yeongtong-gu, Suwon,
Gyeonggi-do, 16229, Korea
6F, C Bldg, Advanced Institute of Convergence Technology

CONTACT

Tel: 82-31-888-9608
Fax: 82-31-888-9601

MORE

Careers: shkim@b-psol.com
Clinical Trials: hsshin@b-psol.com
Investor Inquiries: uklee@b-psol.com
BD Partnering: uklee@b-psol.com